Published research on Melanotan II: record counts, recent publications, reviews and registered studies, pulled from PubMed and ClinicalTrials.gov. Part of other.
Ask TinaTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Registered studies by status: 1 recruiting, 0 active not recruiting, 0 completed.
Number of PubMed records mentioning Melanotan II, 2016 to 2026 (2026 is year to date).
Most recently started of 1 ClinicalTrials.gov entries.
Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental VitiligoNCT07437560 · Recruiting · Phase 2 · started 2026-02-02Primary data for your own interpretation: published studies and regulator documents. No publisher opinion pieces.
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.Mo Med · 2026 Jul-Aug · Moiz A et al. · PubMedPharmacological chaperone action in humanized mouse models of MC4R-linked obesity.JCI Insight · 2021 Feb 22 · René P et al. · PubMedFalsification of biotechnology drugs: current dangers and/or future disasters?J Pharm Biomed Anal · 2018 Aug 20 · Janvier S et al. · PubMedAsk Tina for links to further coverageTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Third-party links, listed for reference. Educational information only, not medical advice. Hypnotic Dose does not endorse any product.